STAAR Surgical (STAA) has drawn investor attention after recent trading saw the stock fall about 7% over the past month and roughly 26% over the past 3 months, with a market value near US$1.1b.

At the current share price of US$22.11, STAAR Surgical has seen short term momentum fade, with the share price down 7.4% over the past month and 26.0% over the past quarter, while the 1 year total shareholder return has declined 19.2%. This points to a period of weaker sentiment despite its longer operating history.

Compare STAAR Surgical's recent pullback with other high quality companies that have also come under pressure by scanning our curated list of 74 resilient stocks with low risk scores.

After a long slide has already removed a large chunk of STAAR Surgical's market value, the key issue now is whether the recent weakness has cleared room for upside or if most of the stock's opportunity is already behind it.

Most Popular Narrative: 25.5% Undervalued

STAAR Surgical's most followed narrative puts fair value at about $29.67 compared with the last close at $22.11, which implies a clear valuation gap that investors will want to understand.

STAAR Surgical has significant cash reserves and no debt, providing a strong financial base to navigate the current challenges, reduce production outputs temporarily, and invest selectively in growth initiatives, potentially stabilizing earnings and providing upside if conditions improve.

Want to see what is driving that valuation gap for STAAR Surgical? The narrative leans on a mix of faster profit growth, firmer margins and a richer future earnings multiple. Curious which of those levers matters most in the fair value math?

Result: Fair Value of $29.67 (UNDERVALUED)

However, STAAR Surgical still faces meaningful risks, including weaker consumer conditions in China and uncertainty around distributor inventory levels, which could unsettle revenue visibility.

Next Steps

With sentiment around STAAR Surgical feeling mixed, this is a good moment to look at the full picture for yourself and move quickly while attention is high. To weigh those concerns against the potential rewards, review the company’s 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond STAAR Surgical?

If you stop with STAAR Surgical, you might miss other opportunities that fit your style. Use the screener to quickly surface stocks that match your priorities.

• Target underpriced quality by reviewing companies that line up in our value focused 44 high quality undervalued stocks.
• Strengthen your income stream by scanning for resilient payers in the 12 dividend fortresses.
• Prioritise resilience by zeroing in on companies featured in the list of solid balance sheet and fundamentals (51 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.